Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

381

HTML

3188

Figures (1-4)

125

Tables (1-3)

129

Sum=3823

May 21, 2012 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 21, 2012; 18(19): 2364-2370
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2364

Full Size Figure Download Figure

Figure 1 Distribution of patients with hilar cholangiocarcinoma from August 1995 to August 2008.

Citation: Isayama H, Tsujino T, Nakai Y, Sasaki T, Nakagawa K, Yamashita H, Aoki T, Koike K. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma. World J Gastroenterol 2012; 18(19): 2364-2370
URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2364.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2364